MHC Class I

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 3-11

  Salter, Russell D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882819439     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50263-4     Document Type: Chapter

References (67)

1. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. PNAS 2003, 100:12889-12894.
2. Androlewicz M., Ortmann B., Endert P., Spies T., Cresswell P. Characteristics of peptide and major histocompatibility complex class I/{beta}2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). PNAS 1994, 91:12716-12720.
3. Balazs I., Beekman J., Neuweiler J., Liu H., Watson E., Ray B. Molecular typing of HLA-A, -B, and DRB using a high throughput micro array format. Hum Immunol 2001, 62:850-857.
4. Beck S., Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu Rev Genomics Hum Genet 2000, 1:117-137.
5. Bjorkman P., Saper M., Samraoui B., Bennett W., Strominger J., Wiley D. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
6. Bjorkman P., Saper M., Samraoui B., Bennett W., Strominger J., Wiley D. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
7. Darji A., Mohamed W., Domann E., Chakraborty T. Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes. Vaccine 2003, 21:S102-S109.
8. DeMars R., Rudersdorf R., Chang C., et al. Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc Natl Acad Sci USA 1985, 82:8183-8187.
9. DeMartino G.N., Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 1999, 274:22123-22126.
10. Diedrich G., Bangia N., Pan M., Cresswell P. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. J Immunol 2001, 166:1703-1709.
11. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
12. Fan Q.R., Garboczi D.N., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. PNAS 1996, 93:7178-7183.
13. Fruh K., Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 1999, 11:76-81.
14. Garboczi D., Ghosh P., Utz U., et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996, 384:134-141.
15. Garin J., Diez R., Kieffer S., et al. The phagosome proteome: insight into phagosome functions. J Cell Biol 2001, 152:165-180.
16. Garrett T., Saper M., Bjorkman P., et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989, 342:692-696.
17. Gil-Torregrosa B., Lennon-Dumenil A., Kessler B., et al. Control of cross-presentation during dendritic cell maturation. Eur J Immunol 2004, 34:398-407.
18. Giorda E., Sibilio L., Martayan A., et al. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells. Cancer Res 2003, 63:4119-4127.
19. Goldberg A.L., Cascio P., Saric T., Rock K.L. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 2002, 39:147-164.
20. Griffin T.A., Nandi D., Cruz M., et al. Immunoprotea-some assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998, 187:97-104.
21. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003, 425:397-402.
22. Guo Z., Hood L., Petersdorf E. Oligonucleotide arrays for high resolution HLA typing. Rev Immunogenet 1999, 1:220-230.
23. Hanada K., Yewdell J., Yang J. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 2004, 427:252-256.
24. Hebart H., Rauser G., Stevanovic S., et al. A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation 1. Exp Hematol 2003, 31:966-973.
25. Heemels M., Schumacher T., Wonigeit K., Ploegh H. Peptide translocation by variants of the transporter associated with antigen processing. Science 1993, 262:2059-2063.
26. Hill A., Elvin J., Willis A., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992, 360:434-439.
27. Jackson M., Cohen-Doyle M., Peterson P., Williams D. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 1994, 263:384-387.
28. Jaffray A., Shephard E., van Harmelen J., Williamson C., Williamson A.-L., Rybicki E.P. Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. J Gen Virol 2004, 85:409-413.
29. Jugovic P., Hill A.M., Tomazin R., Ploegh H., Johnson D.C. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol 1998, 72:5076-5084.
30. Kamarashev J., Ferrone S., Seifert B., et al. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer 2001, 95:23-28.
31. Kovascovics-Bankowski M., Rock K. A phagosometo-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995, 267:243-246.
32. Li J., Schuler-Thurner B., Schuler G., Huber C., Seliger B. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. Int Immunol 2001, 13:1515-1523.
33. Michalek M., Grant E., Gramm C., Goldberg A.L., Rock K. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993, 363:552-554.
34. Nakamura Y., Suda T., Nagata T., et al. Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene. Infect Immun 2003, 71:1748-1754.
35. Neefjes J., Breur-Vriesendorp B., van Seventer G., Ivanyi P., Ploegh H. An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes. Hum Immunol 1986, 16:169-181.
36. Ortmann B., Copeman J., Lehner P., et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997, 277:1306-1309.
37. Papassavas A.C., Stavropoulos-Giokas C. Definition of the immunogenic HLA epitopes based on an epitope prediction algorithm. Transplant Proc 2002, 34:2049-2052.
38. Paquet M.-E., Williams D.B. Mutant MHC class I molecules define interactions between components of the peptide-loading complex. Int Immunol 2002, 14:347-358.
39. Parham P. Monoclonal antibodies against HLA products and their use in immunoaffinity purification. Methods Enzymol 1983, 92:110-138.
40. Parham P., Lawlor D., Lomen C., Ennis P. Diversity and diversification of HLA-A,B,C alleles. J Immunol 1989, 142:3937-3950.
41. Patterson L.J., Malkevitch N., Venzon D., et al. Protection against mucosal Simian immunodeficiency virus SIVmac251 challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol 2004, 78:2212-2221.
42. Peters B., Tong W., Sidney J., Sette A., Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 2003, 19:1765-1772.
43. Petersen J.L., Morris C.R., Solheim J.C. Virus evasion of MHC Class I molecule presentation. J Immunol 2003, 171:4473-4478.
44. Porgador A., Yewdell J., Deng Y., Bennink J., Germain R. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997, 6:715-726.
45. Powis S., Young L., Joly E., et al. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity 1996, 4:159-165.
46. Preckel T., Fung-Leung W.-P., Cai Z., et al. Impaired immunoproteasome assembly and immune responses in PA28/ mice. Science 1999, 286:2162-2165.
47. Princiotta M., Finzi D., et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003, 18:343-354.
48. Quadri S., Singal D. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. Immunol Lett 1998, 61:25-31.
49. Radcliffe C.M., Diedrich G., Harvey D.J., Dwek R.A., Cresswell P., Rudd P.M. Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J Biol Chem 2002, 277:46415-46423.
50. Reits E., Vos J., Gromme M., Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000, 404:774-778.
51. Russmann H., Gerdemann U., Igwe E.I., et al. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect Immun 2003, 71:3463-3472.
52. Sadasivan B., Lehner P., Ortmann B., Spies T., Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996, 5:103-114.
53. Salter R., Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986, 5:934-939.
54. Saxova P., Buus S., Brunak S., Kesmir C. Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol 2003, 15:781-787.
55. Schubert U., Anton L., Gibbs J., Norbury C., Yewdell J., Bennink J. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
56. Schumacher T., Kantesaria D., Serreze D., Roopenian D., Ploegh H. Transporters from H-2b, H-2d, H-2s, H-2k, and H-2g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc Natl Acad Sci USA 1994, 91:13004-13008.
57. Serwold T., Gonzalez F., Kim J., Jacob R., Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002, 419:480-483.
58. Snyder GA., Brooks A.G., Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. PNAS 1999, 96:3864-3869.
59. Strickland E., Hakala K., Thomas P.J., DeMartino GN Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome. J Biol Chem 2000, 275:5565-5572.
60. Sugita K., Miyazaki J., Appella E., Ozato K. Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence. Mol Cell Biol 1987, 7:2625-2630.
61. Suh W.K., Derby M.A., Cohen-Doyle M.F., et al. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain {alpha}3 Domain. J Immunol 1999, 162:1530-1540.
62. Tector M., Salter R.D. Calnexin influences folding of human class I histocompatibility proteins but not their assembly with beta(2)-microglobulin. J Biol Chem 1995, 270:19638-19642.
63. Van Bleek G., Nathenson S. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 1990, 348:213-216.
64. Worgall S., Busch A., Rivara M., et al. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. J Virol 2004, 78:2572-2580.
65. York I., Chang S., Saric T., et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002, 3:1177-1184.
66. Zarling A.L., Luckey C.J., Marto J.A., et al. Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J Immunol 2003, 171:5287-5295.
67. Zhang Q., Tector M., Salter R.D. Calnexin recognizes carbohydrate and protein determinants of class I major histocompatibility complex molecules. J Biol Chem 1995, 270:3944-3948.